EUVIMEDEUVIMED entdecken
Crossref

Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Versus Anti-depressant Medication

Alberto de la Cuadra-Grande iD, Mónica Oltra-Díaz iD, Mara Lerma de Antonio, Miguel Ángel Casado iD, Itziar Oyagüez iD

Applied Health Economics and Health Policy · 2025

DOI: 10.1007/s40258-025-01022-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Health Economics and Health Policy, 2025. Verfasst von Alberto de la Cuadra-Grande und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Psychology and Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, Spain. adelacuadra@porib.com. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Antidepressive Agents, Depression, National Health Programs. Die Arbeit nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cognitive behavioral therapy (CBT) represents an effective psychotherapeutic intervention for patients with depression compared with anti-depressant medications (ADM). OBJECTIVE: The aim of this study was to determine the economically justifiable price (EJP), consisting of an average cost of CBT per patient-year for which the intervention is cost effective versus ADM for the treatment of adults with depression in Spain. METHODS: A patient-level microsimulation model was developed to conduct a cost-utility analysis over the patients' lifetime horizon. Patient demographics, epidemiology of depression, health resources consumption and health utilities feeding the model were sourced from the Spanish national health survey. Additional longitudinal inputs were derived from previously published economic analyses in depression. In the base case, the EJP was estimated for several willingness-to-pay (WTP) thresholds, including €0/QALY (dominancy) and €22,000/QALY. Two scenarios were considered presenting CBT as a substitute of ADM and both CBT and ADM combined (CBT/ADM). The robustness of the model and its results were tested using both deterministic and probabilistic sensitivity analyses. RESULTS: For the scenario of CBT versus ADM, the EJP was estimated at €5236 for a WTP threshold of €22,000/QALY. At an EJP of €549, CBT was a dominant intervention compared with ADM. In the scenario considering CBT/ADM versus ADM, the EJP was €5449, CBT/ADM being dominant at an EJP of €255. Sensitivity analyses demonstrated that the base-case results were robust. CONCLUSION: CBT and CBT/ADM achieved incremental health benefits compared with ADM. Under the estimated EJPs, CBT and CBT/ADM could represent a cost effective or dominant intervention for adult patients with depression in Spain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Behavioral TherapyAntidepressive AgentsDepressionNational Health ProgramsHumansSpainCost-Benefit AnalysisMaleAdultFemaleMiddle AgedQuality-Adjusted Life YearsAged

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Social Psychology and Methodology, School of Psychology, Universidad Autónoma de Madrid, Madrid, Spain. adelacuadra@porib.com.
  • Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4-Letter I, 28224, Madrid, Spain. adelacuadra@porib.com.
  • Centro de Atención Temprana AFANDICE, Madrid, Spain.
  • Sanitary Psychologist, Madrid, Spain.
  • Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4-Letter I, 28224, Madrid, Spain.
  • Fundación PORIB, Madrid, Spain.

ORCID-Profile: Alberto de la Cuadra-Grande, Mónica Oltra-Díaz, Miguel Ángel Casado, Itziar Oyagüez

Zitieren

APA

de la Cuadra-Grande, A., Oltra-Díaz, M., Lerma de Antonio, M., Casado, M. Á., & Oyagüez, I. (2025). Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Versus Anti-depressant Medication. Applied Health Economics and Health Policy. https://doi.org/10.1007/s40258-025-01022-2

Vancouver

de la Cuadra-Grande A, Oltra-Díaz M, Lerma de Antonio M, Casado MÁ, Oyagüez I. Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Versus Anti-depressant Medication. Applied Health Economics and Health Policy. 2025. doi:10.1007/s40258-025-01022-2

BibTeX
@article{delaCuadraGrande2025,
  author = {de la Cuadra-Grande, Alberto and Oltra-Díaz, Mónica and Lerma de Antonio, Mara and Casado, Miguel Ángel and Oyagüez, Itziar},
  title = {Should the Spanish National Health System Invest in Psychotherapy for Depression? A Microsimulation Cost-Utility Study to Estimate the Economically Justifiable Price of Cognitive Behavioral Therapy Versus Anti-depressant Medication},
  journal = {Applied Health Economics and Health Policy},
  year = {2025},
  doi = {10.1007/s40258-025-01022-2}
}
Kostenlos starten →